Skip to main content
. 2023 Apr 17;43(11):1357–1366. doi: 10.1093/asj/sjad100

Figure 3.

Figure 3.

Participants achieving a 3-point improvement on the AIHS following treatment with VYC-15L. A 53-year-old female participant at (A) baseline with AIHS score = 3 (severe, both sides), at (B) Month 3 with AIHS score = 1 (none, left side) and 0 (none, right side), and at (C) Month 12 with AIHS score = 0 (none, both sides) following initial treatment volume of 0.9 mL (left side) and 0.9 mL (right side) total. A 38-year-old male participant at (D) baseline with AIHS score = 3 (severe, both sides), at (E) Month 3 with AIHS score = 0 (none, both sides), and at (F) Month 12 with AIHS score = 0 (none, both sides) following initial + touch-up treatment volume of 1.1 mL (left) and 1.2 mL (right) total. AIHS, Allergan Infraorbital Hollow Scale.